PUF Ventures Inc. (CSE:PUF, Frankfurt:PU3, OTCPK:PUFXF) , and Natures Hemp Corp. (“Natures Hemp”) are pleased to announce that effective August 28, 2018 (the “Effective Date”), they completed a statutory arrangement under a plan of arrangement (the “Arrangement”). As a result of completing the Arrangement, Natures Hemp became a reporting issuer in the provinces of British Columbia, Alberta and Ontario.
Completion of the Arrangement, as set forth in the arrangement agreement and plan of arrangement dated May 18, 2018 (the “Arrangement Agreement”), between PUF and Natures Hemp Corp. was approved by the shareholders of PUF on August 7, 2018 and by a Final Order granted by the Supreme Court of British Columbia on August 13, 2018, in accordance with Part 9 of the Business Corporations Act (British Columbia).
Natures Hemp Corp.:
Pursuant to the Arrangement Agreement and on the Effective Date, the following occurred:
|(a)||PUF distributed 100% of the common shares of Natures Hemp (“Natures Hemp Shares”) it received to the shareholders of PUF (the “PUF Shareholders”) on a pro rata basis. The PUF Shareholders received one Natures Hemp Share in exchange for every 3.3665 common shares of PUF held as at the Record Date, June 18, 2018;|
|(b)||PUF transferred the assets to Natures Hemp;|
|(c)||Natures Hemp became a reporting issuer in the Provinces of British Columbia, Alberta and Ontario;|
|(d)||PUF retained its working capital for its assets, remains listed on the CSE and will continue to trade under the trading symbol, PUF, as a consumer products – biotechnology/pharmaceuticals company; and|
|(e)||Natures Hemp completed the conversion of 11,666,000 special warrants into Natures Hemp Shares.|
The CUSIP number for the common shares of Natures Hemp is 639021104.
As of the Effective Date, the board of directors of Natures Hemp are Derek Ivany, David Parry and Robert V. Matthewsand the officers of Natures Hemp are Derek Ivany, CEO and Sean McGrath, CFO.
About the Company
PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies: AAA Heidelberg, Solaris Nutraceuticals Pty Ltd., and Natures Hemp Corp., and is actively pursuing other opportunities within the industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., a private Ontario company and advanced applicant for an ACMPR license. Solaris Nutraceuticals is building the largest medical cannabis greenhouse in the Southern Hemisphere. For more information please visit: www.puf.ca.
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of the release.
Some of the statements contained in the release are forward-looking statements, such as estimates and statements that describe the Company’s future plans, objectives or goals, including words to the effect that the Company or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.
For further information: regarding PUF Ventures Inc. or Natures Hemp Corp. please contact: Derek Ivany, President & CEO; For additional information: PUF Ventures Inc., E: firstname.lastname@example.org, T: (800) 783-6056
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).